Kura Oncology to Report Fourth Quarter and Full Year 2022

Kura Oncology to Report Fourth Quarter and Full Year 2022

SAN DIEGO, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the......

Arbutus to Report Fourth Quarter and Year End 2022

Arbutus to Report Fourth Quarter and Year End 2022

WARMINSTER, Pa., Feb. 16, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging......

Intellia Therapeutics to Hold Conference Call to Discuss

Intellia Therapeutics to Hold Conference Call to Discuss

CAMBRIDGE, Mass., Feb. 16, 2023 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage genome editing company focused on......

Decibel Therapeutics to Present at the Upcoming SVB

Decibel Therapeutics to Present at the Upcoming SVB

BOSTON, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and......

Shattuck Labs to Report Fourth-Quarter and Full-Year 2022

Shattuck Labs to Report Fourth-Quarter and Full-Year 2022

AUSTIN, TX & DURHAM, NC, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company......

Sonder Holdings Inc. to Report Fourth Quarter and Full Year

Sonder Holdings Inc. to Report Fourth Quarter and Full Year

SAN FRANCISCO, Feb. 15, 2023 (GLOBE NEWSWIRE) -- Sonder Holdings Inc. (NASDAQ: SOND), a leading next-generation hospitality company that is redefining......

Retail Opportunity Investments Corp. Reports 2022 Results

Retail Opportunity Investments Corp. Reports 2022 Results

SAN DIEGO, Feb. 15, 2023 (GLOBE NEWSWIRE) -- Retail Opportunity Investments Corp. (NASDAQ:ROIC) announced today financial and operating results for the......

StoneCo Announces Board Changes

StoneCo Announces Board Changes

GEORGETOWN, Cayman Islands, Feb. 15, 2023 (GLOBE NEWSWIRE) -- StoneCo Ltd. (Nasdaq: STNE) (“Stone” or the “Company”), a leading provider of financial......

Atea Pharmaceuticals to Present Data on Bemnifosbuvir Drug

Atea Pharmaceuticals to Present Data on Bemnifosbuvir Drug

BOSTON, Feb. 15, 2023 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”), a clinical-stage biopharmaceutical company, today announced......

Distoken Acquisition Corporation Announces Pricing of $60.0

Distoken Acquisition Corporation Announces Pricing of $60.0

NEW YORK, Feb. 15, 2023 (GLOBE NEWSWIRE) -- Distoken Acquisition Corporation (Nasdaq: DISTU) (the “Company”), a Cayman Islands exempted company formed......

  • 1
  • ...
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • ...
  • 44
  • menu
    menu